Patterns of questionable quality care in nonmuscle invasive bladder cancer

Cancer

Volumn 116, Issue 11, 2010, Pages 2508-2510

  Gore, John L ^a   Porter, Michael P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; COST OF ILLNESS; CYSTOSCOPY; DISEASE COURSE; EDITORIAL; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; MEDICARE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; HUMANS; NEOPLASM INVASIVENESS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; URINARY BLADDER NEOPLASMS;

EID: 77952862069     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25020     Document Type: Editorial

References (10)

1. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21:1315-1330. (Pubitemid 38041357)
2. Edge SB, Byrd DR. American Joint Committee on Cancer cancer staging manual. New York: Springer; 2009.
3. Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD. Provider treatment intensity and outcomes for patients with early-stage bladder cancer. J Natl Cancer Inst. 2009; 101:571-580.
4. Schrag D, Hsieh LJ, Rabbani F, Bach PB, Herr H, Begg CB. Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst. 2003;95:588-597. (Pubitemid 36553505)
5. Montie JE, Clark PE, Eisenberger MA, et al. Bladder cancer. J Natl Compr Canc Netw. 2009;7:8-39.
6. Jones JS, Campbell SC. Non-Muscle-Invasive Bladder Cancer (Ta, T1, and CIS). In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders; 2006:2447-2467.
7. Herr HW. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol. 2000;163:60-61; discussion 61-62.
8. Han RF, Pan JG. Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology. 2006; 67:1216-1223.
9. Nieder AM, Brausi M, Lamm D, et al. Management of stage T1 tumors of the bladder: International Consensus Panel. Urology. 2005;66(6 suppl 1):108-125. (Pubitemid 43049612)
10. Strope SA, Ye Z, Hollingsworth JM, Hollenbeck BK. Patterns of Care for Early Stage Bladder Cancer. Cancer. 2010;116;2604-2611.